Eventide Asset Management, LLC 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:06 pm Sale |
2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,606,938 5.430% |
-838,425 (-24.33%) |
Filing |
| 2024-11-14 12:25 pm Purchase |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 3,445,363 7.220% |
751,782 (+27.91%) |
Filing |
| 2024-02-14 12:49 pm Purchase |
2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,693,581 5.780% |
636,581 (+30.95%) |
Filing |
| 2023-02-14 1:34 pm Purchase |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,057,000 5.600% |
2,057,000 (New Position) |
Filing |